Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research

Expert Rev Anti Infect Ther. 2018 May;16(5):377-380. doi: 10.1080/14787210.2018.1473764. Epub 2018 May 8.
No abstract available

Keywords: CHC; Cannabis; HCV; HIV; co-infection; hepatitis; liver disease; marijuana; steatosis.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cannabinoids / administration & dosage
  • Cannabinoids / pharmacology*
  • Coinfection
  • Fatty Liver / etiology
  • Fatty Liver / prevention & control*
  • HIV Infections / complications
  • HIV Infections / epidemiology
  • Hepatitis C, Chronic / complications
  • Hepatitis C, Chronic / epidemiology
  • Humans
  • Marijuana Smoking / epidemiology*
  • Protective Factors
  • Risk Factors

Substances

  • Cannabinoids